Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Carcinoma × Aspirin × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 22 Neoplasms 13 Colonic Neoplasms 10 Breast Neoplasms 10 Venous Thromboembolism 8 Prostatic Neoplasms 8 Multiple Myeloma 7 Recurrence 6 Polycythemia Vera 6 Carcinoma, Non-Small-Cell Lung 6 Thrombocythemia, Essential 4 Neoplasms, Plasma Cell 4 Ovarian Neoplasms 3 Neoplasm Metastasis 3 Melanoma 3 Thrombosis 2 Sarcoma 2 Rectal Neoplasms 2 Primary Myelofibrosis 2 Pancreatic Neoplasms 2 Neoplastic Cells, Circulating 2 Neoplasms by Site 2 Myocardial Infarction 2 Lung Neoplasms 2 Intestinal Neoplasms 2 Intestinal Diseases 2 Inflammation 2 Gastrointestinal Neoplasms 2 Fallopian Tube Neoplasms 2 Esophageal Neoplasms 2

Interventions

Cisplatin 21 Gemcitabine 16 pembrolizumab 15 Paclitaxel 15 Radiotherapy 14 Radiotherapy, Intensity-Modulated 13 Carboplatin 12 Cyclophosphamide 9 Cetuximab 9 Magnetic Resonance Spectroscopy 8 Radiation 7 padeliporfin 6 Specimen Handling 6 Oxaliplatin 6 Fluorouracil 6 Drug Therapy 6 Docetaxel 6 Capecitabine 6 Bevacizumab 6 anlotinib 5 Nivolumab 5 Irinotecan 5 poly ICLC 4 fludarabine 4 Standard of Care 4 Sorafenib 4 Leucovorin 4 Ipilimumab 4 Erlotinib Hydrochloride 4 Celecoxib 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07529262 2026-04-14

AspiRe HCC

Curtin University

Phase 3 Not yet recruiting

Carcinoma, Fibrosis, Liver Cirrhosis, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡